Browsing by Subject "Donepezil"
Now showing items 1-2 of 2
-
A pharmacovigilance study of gender differences in rhabdomyolysis risk among donepezil users with alzheimer`s disease
(Brac University, 2023-10)Alzheimer’s disease is the most common disease for older patients marked by symptoms of dementia. This study was conducted for the pharmacovigilance investigation of donepezil related to adverse event rhabdomyolysis among ... -
A pharmacovigilance study on Donepezil: signal detection of rhabdomyolysis and death
(Brac University, 2023-02)Alzheimer’s disease is an age-related neurodegenerative disease that effects the cognitive ability of a person. The cholinesterase inhibitor “donepezil” is used to treat Alzheimer's disease. Donepezil has shown the greatest ...
